Pharmacotherapy of major depressive disorder in adolescents

Bibliography

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. American Psychiatric Association, Washington, DC; 1994
   Google Scholar
• Costello EJ, Foley DL, Angold A. 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology. J Am Acad Child Adolesc Psychiatry 2006;45:8-25
   PubMed Web of Science ®Google Scholar
• Kovacs M, Feinberg TL, Crouse-Novak M, Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 1984;41:643-9
   PubMed Web of Science ®Google Scholar
• Weissmann MM, Wolk S, Goldstein RB, Depressed adolescents grown up. J Am Med Assn 1999;281:1707-13
   Google Scholar
• Fombonne E, Wostear G, Cooper V, The Maudsley long-term follow-up of child and adolescent depression. 2. Suicidality, criminality and social dysfunction in adulthood. Br J Psychiatry 2001;179:218-23
   PubMed Web of Science ®Google Scholar
• National Center for Injury Prevention and Control. Suicide in the United States. Centers for Disease Control and Prevention, Atlanta, GA; 2002
   Google Scholar
• Geller B, Zimerman B, Williams M, Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 2001;158:125-7
   PubMed Web of Science ®Google Scholar
• Martin A, Young C, Leckman JF, Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 2004;158:773-80
   PubMed Web of Science ®Google Scholar
• Masi G, Toni C, Perugi G, The clinical phenotypes of juvenile bipolar disorder: toward a validation of the episodic-chronic distinction. Biol Psychiatry 2006;59:603-10
   Google Scholar
• Masi G, Perugi G, Millepiedi S, Clinical implications of DSM-IV subtyping of bipolar disorders in referred children and adolescents. J Am Acad Child Adolesc Psychiatry 2007;46:1299-306
   Google Scholar
• Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: a case control study. Arch Gen Psychiatry 2006;63:865-72
   PubMed Web of Science ®Google Scholar
• Harrington R, Whittaker J, Shoebridge P, Campbell F. Systematic review of cognitive behavioral therapies in childhood and adolescent depressive disorder. Br Med J 1998;316:1559-63
   PubMed Web of Science ®Google Scholar
• Compton SN, March JS, Brent D, Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004;43:930-59
   PubMed Web of Science ®Google Scholar
• Weisz JR, McCarthy CA, Valeri SM. Effect of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006;132:132-49
   PubMed Web of Science ®Google Scholar
• Mufson L, Dorta KP, Wickramaratne P, A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 2004;61:577-84
   PubMed Web of Science ®Google Scholar
• Renaud J, Brent DA, Baugher M, Rapid response to psychosocial treatment for adolescent depression: a 2-year follow-up. J Am Acad Child Adolesc Psychiatry 1998;37:1184-90
   PubMed Web of Science ®Google Scholar
• Birmaher B, Brent D, Kolko D, Clinical outcome after short-term psychotherapy for adolescent with major depressive disorder. Arch Gen Psychiatry 2000;57:29-36
   PubMed Web of Science ®Google Scholar
• Tads Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescent with depression. Treatment for Adolescent with Depression Study (TADS) randomized controlled trial. J Am Med Assn 2004;292:807-20
   Google Scholar
• Weersing VR, Brent DA. Cognitive behavioral therapy for depression in youth. Child Adolesc Psychiatr Clin North Am 2006;15:939-57
   PubMed Web of Science ®Google Scholar
• TADS Team. The Treatment for Adolescent with Depression Study (TADS). Long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007;64:1132-44
   PubMed Web of Science ®Google Scholar
• March JS, Silva S, Petrycki S, The Treatment of Adolescent Depression Study (TADS): long term effectiveness and safety outcomes. Arch Gen Psychiatry 2007;64:1132-43
   PubMed Web of Science ®Google Scholar
• Kratochvil C, Emslie G, Silva S; TADS Team. Acute time to response in the Treatment of Adolescent Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:1412-8
   PubMed Web of Science ®Google Scholar
• Vitiello B, Rohde P, Silva S, Functioning and quality of life in the Treatment of Adolescent Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:1419-26
   PubMed Web of Science ®Google Scholar
• Kennard B, Silva S, Vitiello B; TADS Team. Remission and residual symptoms after short term treatment in the Treatment of Adolescent Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:1404-11
   PubMed Web of Science ®Google Scholar
• Kennard B, Silva S, Toney S. Remission and recovery in the Treatment of Adolescent Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 2009. [Epub ahead of print]
   Google Scholar
• Emslie G, Kratochvil C, Vitiello B, Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 2006;45:1440-55
   PubMed Web of Science ®Google Scholar
• Curry J, Rohde P, Simons S, Predictors and moderators of acute outcome in the Treatment of Adolescent Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:1427-39
   PubMed Web of Science ®Google Scholar
• Domino ME, Foster ME, Vitiello B. Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. J Am Acad Child Adolesc Psychiatry 2009;48:711-20
   PubMed Web of Science ®Google Scholar
• Brent D, Emslie G, Clarke G, Switching to another SSRI or venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. J Am Med Assn 2008;299:910-3
   Google Scholar
• Goodyer I, Dubicka B, Wilkinson P, Selective Serotonin Reuptake Inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. Br Med J 2007;335:106-7
   Google Scholar
• Wilkinson P, Dubicka B, Kelvin R, Treated depression in adolescents: predictors of outcome at 28 weeks. Br J Psychiatry 2009;194:334-41
   PubMed Web of Science ®Google Scholar
• Hazell P, O’Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002;(2):CD002317
   PubMedGoogle Scholar
• Emslie GJ, Rush AJ, Weiberg WA, A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Heiligenstein JH, Wagner KD, Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002b;41:1205-15
   PubMed Web of Science ®Google Scholar
• Wagner KD, Ambrosini P, Rynn M, Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA 2003;290:1033-41
   PubMed Web of Science ®Google Scholar
• Wagner KD, Robb AS, Findling RL, A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 2004;161:1079-83
   PubMed Web of Science ®Google Scholar
• Von Knorring AL, Olson GI, Thomsen PH, A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. J Clin Psychopharmacol 2006;26:311-5
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry 2009;48:721-9
   PubMed Web of Science ®Google Scholar
• Wagner KD, Jonas J, Findling RL, A double-blind, randomized, placebo-controlled study of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-8
   PubMed Web of Science ®Google Scholar
• Keller MB, Ryan ND, Strober M, Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Wagner KD, Kutcher S, Paroxetine treatment in children and adolescents with major depressive disorder: a randomised, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2006b;45:709-19
   PubMed Web of Science ®Google Scholar
• Berard R, Fong R, Carpenter DJ, An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. J Child Adolesc Psychopharmacol 2006;16:59-75
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Findling RL, Yeung PP, Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo controlled trials. J Am Acad Child Adolesc Psychiatry 2007;46:479-88
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled clinical trials. JAMA 2007;297:1683-96
   PubMed Web of Science ®Google Scholar
• Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ. Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry 2008;193:10-7
   PubMed Web of Science ®Google Scholar
• Usala T, Clavenna A, Zuddas A, Bonati M. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol 2008;18:62-73
   PubMed Web of Science ®Google Scholar
• March J, Silva S, Susan J; TADS Team. The treatment of adolescents with depression study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry 2009;166:1141-9
   PubMed Web of Science ®Google Scholar
• Asarnow JR, Emslie G, Clarke G, Treatment of serotonin reuptake inhibitors – resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009;48:330-9
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Borges G, Trends in suicide ideation, plans, gestures, and attempts in the United States. J Am Med Assn 2005;293:2487-95
   PubMed Web of Science ®Google Scholar
• Evans E, Hawton K, Rodham K, Deeks J. The prevalence of suicidal phenomena in adolescents: a systematic review of population-based studies. Suicide Life Threat Behav 2005;35:239-50
   PubMed Web of Science ®Google Scholar
• Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-9
   PubMed Web of Science ®Google Scholar
• Whittington GJ, Kendall T, Fonagy P, Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5
   PubMed Web of Science ®Google Scholar
• Mosholder AD, Willy M. Suicidal adverse events in pediatric Randomized, controlled clinical trials of antidepressants drugs are associated with active drug treatment: a meta-analysis. J Child Adolesc Psychopharmacol 2006;16:25-32
   PubMed Web of Science ®Google Scholar
• Wohlfarth TD, van Zwieten BJ, Lekkerkerker FJ, Antidepressant use in children and adolescents and the risk of suicide. Eur Neuropsychopharmacol 2006;16:79-83
   PubMed Web of Science ®Google Scholar
• Vitiello B, Silva S, Rohde P, Suicidal events in the Treatment for Adolescents with Depression Study (TADS). J Clin Psychiatry 2009;70:741-7
   PubMed Web of Science ®Google Scholar
• Brent D, Emslie G, Clarke GM, Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009;166:418-26
   PubMed Web of Science ®Google Scholar
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicide behaviors. J Am Mad Assn 2004;292:338-43
   PubMed Web of Science ®Google Scholar
• Martinez C, Rietbrock S, Wise L, Antidepressant treatment and the risk of fatal and non fatal self-harm in the first episode depression: nested case-control study. Br Med J 2005;330:389
   PubMed Web of Science ®Google Scholar
• Simon GE, Savarino J. Suicide attempts among patients starting antidepressant treatment with medication or psychotherapy. Am J Psychiatry 2007;164:1029-34
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry 2008;69:425-32
   Google Scholar
• Stone M, Laughren, Jones ML, Risk of suicidality in clinical antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. Br Med J 2009;339:b2880
   PubMed Web of Science ®Google Scholar
• McKeown RE, Cuffe SP, Schulz RM. US suicide rates by age group, 1970-2002: an examination of recent trends. Am J Public Health 2006;96:1744-51
   PubMed Web of Science ®Google Scholar
• Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003;60:978-82
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Brown CH, Hur K, Early evidence on the effects of regulators suicidality warnings on SSRI prescriptions and suicide in adolescents. Am J Psychiatry 2007;164:1356-63
   PubMed Web of Science ®Google Scholar
• Vitiello B, Brent D, Greenhill LL, Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters study. J Am Acad Child Adolesc Psychiatry 2009b. [Epub ahead of print]
   Google Scholar
• Brent D, Greenhill LL, Compton, The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in a open treatment trial. J Am Acad Child Adolesc Psychiatry 2009b. [Epub ahead of print]
   Google Scholar
• Bridge JA, Birmaher B, Ivengar S, Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009;166:1-3
   Google Scholar
• Joyce PR, Mulder RT, Luty SE, Age-dependent antidepressant pharmacogenomics: polymorphism of the serotonin transporter and G-protein beta-3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol 2003;6:339-46
   PubMed Web of Science ®Google Scholar
• Rynn MA, Riddle MA, Yeung PP, Kunz NR. Efficacy and safety of extended release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry 2007;164:290-300
   PubMed Web of Science ®Google Scholar
• March JS, Entusah AR, Rynn M, A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry 2007;62:1149-54
   PubMed Web of Science ®Google Scholar
• Geller DA, Biederman J, Stewart SE, Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003;160:1919-28
   PubMed Web of Science ®Google Scholar
• Strober M, Freeman R, Rigal J, The pharmacotherapy of depressive illness in adolescence. II: effects of lithium augmentation in non-responders to imipramine. J Am Acad Child Adolesc Psychiatry 1992;31:16-20
   PubMed Web of Science ®Google Scholar
• Masi G, Milone AR, Manfredi A, Effectiveness of lithium in adolescents with conduct disorders. CNS Drugs 2009;23:59-69
   PubMed Web of Science ®Google Scholar